4DMedical is trading 5.38% lower at A$3.87; Australian IT weakness may have contributed, but no direct cause is established.

  • No new company-specific announcement was identified for October 19.
  • Latest cited filings, dated October 16, were an AGM addendum and a securities quotation application.
  • The ASX 200 rose 0.44%, while Australian IT stocks fell about 2%, mirroring weakness in U.S. technology shares.